Abstract
Herein, we report the In2S3 and rubidium doped In2S3 (Rb- In2S3) nanostructures and elucidate their role in α-glucosidase inhibition (AIGs). The phase, crystal structure, morphology, and composition of the as prepared In2S3 and Rb- In2S3 nanostructures was characterized by PXRD, SEM, TEM and EDS analysis, respectively. Pure In2S3 were unable to impart significance glucosidase inhibition activity, while the activity was remarkably enhanced with the doping of 5% Rb. The mass percentage of Rb (0.42 μg ml−1) is much lower than the transition metals-based drugs reported in the literature.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
